Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX)

CUSIP: 22053A107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.0001 par value
Shares outstanding
55,541,178
Total 13F shares
18,545,330
Share change
-159,949
Total reported value
$982,908,976
Put/Call ratio
72%
Price per share
$53.00
Number of holders
104
Value change
-$6,104,699
Number of buys
65
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 22053A107?
CUSIP 22053A107 identifies QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) as of Q2 2021

As of 30 Jun 2021, Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,545,330 shares. The largest 10 holders included EPIQ Capital Group, LLC, Capital World Investors, Capital International Investors, Capital Research Global Investors, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, SC US (TTGP), LTD., GEODE CAPITAL MANAGEMENT, LLC, and PACIFIC HEIGHTS ASSET MANAGEMENT LLC. This page lists 104 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.